Search Results - "Jing, Changwen"

Refine Results
  1. 1

    Cytokine-induced killer cells as a feasible adoptive immunotherapy for the treatment of lung cancer by Chen, Dan, Sha, Huanhuan, Hu, Tianmu, Dong, Shuchen, Zhang, Junying, Liu, Siwen, Cao, Haixia, Ma, Rong, Wu, Yang, Jing, Changwen, Wang, Zhuo, Wu, Jianzhong, Feng, Jifeng

    Published in Cell death & disease (06-03-2018)
    “…Most of the patients with lung cancer are diagnosed at advanced stage, and they often lose the opportunity of surgical therapy, most of whom fail to reach good…”
    Get full text
    Journal Article
  2. 2

    New genetic variations discovered in KRAS wild‐type cetuximab resistant chinese colorectal cancer patients by Jing, Changwen, Wang, Ting, Ma, Rong, Cao, Haixia, Wang, Zhuo, Liu, Siwen, Chen, Dan, Zhang, Junying, Wu, Yang, Zhang, Yuan, Wu, Jianzhong, Feng, Jifeng

    Published in Molecular carcinogenesis (01-05-2020)
    “…To perform a comprehensive genomic analysis of colorectal cancer (CRC) tumor to detect genetic variants and identify novel resistant mutations associated with…”
    Get full text
    Journal Article
  3. 3

    The somatic mutation landscape of Chinese Colorectal Cancer by Ma, Rong, Jing, Changwen, Zhang, Yuan, Cao, Haixia, Liu, Siwen, Wang, Zhuo, Chen, Dan, Zhang, Junying, Wu, Yang, Wu, Jianzhong, Feng, Jifeng

    Published in Journal of Cancer (2020)
    “…Colorectal cancer (CRC) is the fifth leading cause of cancer-related death in China. The incidence of Chinese CRC has increased dramatically with the changes…”
    Get full text
    Journal Article
  4. 4

    Rupatadine-inhibited OTUD3 promotes DLBCL progression and immune evasion through deubiquitinating MYL12A and PD-L1 by Sui, Ying, Shen, Ziyang, Li, Xiaoyou, Lu, Ya, Feng, SiTong, Ma, Rong, Wu, Jianzhong, Jing, Changwen, Wang, Zhuo, Feng, Jifeng, Cao, Haixia

    Published in Cell death & disease (03-08-2024)
    “…The obstacle to effectively treating Diffuse Large B-cell Lymphoma (DLBCL) lies in the resistance observed toward standard therapies. Identifying therapeutic…”
    Get full text
    Journal Article
  5. 5

    The analysis of the circRNAs in the progress of acquired resistance to Cetuximab by Yin, Liping, Jing, Changwen, Guo, Yesong

    Published in Precision medical sciences (01-06-2022)
    “…We established a Cetuximab‐resistant cell lines by high‐dose pulse method and searched for differentially expressed circular RNAs by RNA sequencing. Hundreds…”
    Get full text
    Journal Article
  6. 6

    Comparison of droplet digital PCR and direct Sanger sequencing for the detection of the BRAF V600E mutation in papillary thyroid carcinoma by Wang, Zhuo, Sun, Kejing, Jing, Changwen, Cao, Haixia, Ma, Rong, Wu, Jianzhong

    Published in Journal of clinical laboratory analysis (01-07-2019)
    “…The BRAF mutation status is a useful diagnostic and prognostic marker for papillary thyroid carcinoma (PTC). Although it is a commonly used method, Sanger…”
    Get full text
    Journal Article
  7. 7

    LXR activation causes G1/S arrest through inhibiting SKP2 expression in MIN6 pancreatic beta cells by Li, Yating, Jing, Changwen, Tang, Xinyi, Chen, Yuanyuan, Han, Xiao, Zhu, Yunxia

    Published in Endocrine (01-09-2016)
    “…Liver X receptors (LXRs) are nuclear hormone receptors with central roles in lipid homeostasis. We previously showed that LXR activation induced aberrant lipid…”
    Get full text
    Journal Article
  8. 8

    Nedaplatin reduces multidrug resistance of non-small cell lung cancer by downregulating the expression of long non-coding RNA MVIH by Jing, Changwen, Wang, Zhuo, Lou, Rui, Wu, Jianzhong, Shi, Chen, Chen, Dan, Ma, Rong, Liu, Siwen, Cao, Haixia, Feng, Jifeng

    Published in Journal of Cancer (2020)
    “…Cisplatin-based chemotherapy is the standard treatment for non-small cell lung cancer (NSCLC). However, drug resistance emergences after treatment. Long…”
    Get full text
    Journal Article
  9. 9

    The Function Role of miR-181a in Chemosensitivity to Adriamycin by Targeting Bcl-2 in Low-Invasive Breast Cancer Cells by Zhu, Ying, Wu, Jianzhong, Li, Shuchun, Ma, Rong, Cao, Haixia, Ji, Minghua, Jing, Changwen, Tang, Jinhai

    Published in Cellular physiology and biochemistry (01-01-2013)
    “…Objectives: miR-181a is involved in immunity, metabolism, tumor suppression or carcinogenesis reported by many other studies. However, its role in the…”
    Get full text
    Journal Article
  10. 10

    Long noncoding RNA and mRNA profiling in cetuximab‐resistant colorectal cancer cells by RNA sequencing analysis by Jing, Changwen, Ma, Rong, Cao, Haixia, Wang, Zhuo, Liu, Siwen, Chen, Dan, Wu, Yang, Zhang, Junying, Wu, Jianzhong

    Published in Cancer medicine (Malden, MA) (01-04-2019)
    “…To gain an insight into the molecular mechanisms of cetuximab resistance in colorectal cancer, we generated a cetuximab‐resistant cell line (H508/CR) and…”
    Get full text
    Journal Article
  11. 11

    Next generation sequencing based detection of 15 target genes mutations in papillary thyroid carcinoma by Wang, Zhuo, Jing, Changwen, Cao, Haixia, Liu, SiWen, Wu, Jianzhong, Ma, Rong

    Published in Precision medical sciences (01-11-2020)
    “…Objectives Next generation sequencing (NGS) method provided a valuable tool for a comprehensive understanding of papillary thyroid carcinoma (PTC) biology. We…”
    Get full text
    Journal Article
  12. 12

    Association between mutation profiles and clinicopathological features in Chinese patients with thyroid cancer by Jing, Changwen, Cao, Haixia, Ma, Rong, Wu, Jianzhong, Wang, Zhuo

    Published in Precision medical sciences (01-09-2021)
    “…Recently, mutation profiles provided new insights into comprehensive understanding of TC biology by Next Generation Sequencing (NGS). We explored association…”
    Get full text
    Journal Article
  13. 13

    Rare and novel GNAS gene mutations in Chinese patients with thyroid cancer by Wang, Zhuo, Jing, Changwen, Cao, Haixia, Wu, Jianzhong, Ma, Rong

    Published in Precision medical sciences (01-06-2021)
    “…Background A large number of novel, rare, and uncharacterized mutations in Tumors including thyroid cancer (TC) have been discovered. In this study, we…”
    Get full text
    Journal Article
  14. 14

    Long noncoding RNA ZMIZ1‐AS1 promotes gefitinib resistance via binding to hnRNPA1 by Jing, Changwen, Cao, Haixia, Wu, Jianzhong, Ma, Rong, Zhang, Junying, Liu, Siwen, Wang, Zhuo

    Published in Precision medical sciences (01-09-2021)
    “…To gain an insight into the molecular mechanisms of gefitinib resistance in nonsmall cell lung cancer, we screened out the long noncoding RNA related to…”
    Get full text
    Journal Article
  15. 15

    Liver X receptor agonist T0901317 reverses resistance of A549 human lung cancer cells to EGFR‐TKI treatment by Cao, Haixia, Yu, Shaorong, Chen, Dan, Jing, Changwen, Wang, Zhuo, Ma, Rong, Liu, Siwen, Ni, Jie, Feng, Jifeng, Wu, Jianzhong

    Published in FEBS open bio (01-01-2017)
    “…Epidermal growth factor receptor‐tyrosine kinase inhibitor (EGFR‐TKI) is effective in lung cancer patients carrying sensitive EGFR mutations. In this study, we…”
    Get full text
    Journal Article
  16. 16

    Huntingtin-associated protein 1: A potential biomarker of breast cancer by ZHU, LIWEI, SONG, XUE, TANG, JINHAI, WU, JIANZHONG, MA, RONG, CAO, HAIXIA, JI, MINGHUA, JING, CHANGWEN, WANG, ZHUO

    Published in Oncology reports (01-05-2013)
    “…It is reported that patients with Huntington's disease (HD) have a low incidence of cancer. In this study, we investigated the expression of…”
    Get full text
    Journal Article
  17. 17

    Resveratrol prevents interleukin-1 β-induced dysfunction of pancreatic β-cells by Chen, Fang, Zhou, Xiaohua, Lin, Yan, Jing, Changwen, Yang, Tao, Ji, Yong, Sun, Yujie, Han, Xiao

    Published in Journal of biomedical research (01-09-2010)
    “…Objective:Interleukin-1β(IL-1β)plays an important role in the development of type 1 and type 2 diabetes mellitus.Resveratrol,a polyphenol,is known to have a…”
    Get full text
    Journal Article
  18. 18

    Exosome-mediated gefitinib resistance in lung cancer HCC827 cells via delivery of miR-21 by Jing, Changwen, Cao, Haixia, Qin, Xiaobing, Yu, Shaorong, Wu, Jianzhong, Wang, Zhuo, Ma, Rong, Feng, Jifeng

    Published in Oncology letters (01-06-2018)
    “…Acquired resistance to gefitinib remains a major challenge in cancer treatment. In the present study, the effect of exosomes on the transmission of gefitinib…”
    Get full text
    Journal Article
  19. 19

    Next‑generation sequencing‑based detection of EGFR, KRAS, BRAF, NRAS, PIK3CA, Her‑2 and TP53 mutations in patients with non‑small cell lung cancer by Jing, Changwen, Mao, Xuhua, Wang, Zhuo, Sun, Kejing, Ma, Rong, Wu, Jianzhong, Cao, Haixia

    Published in Molecular medicine reports (01-08-2018)
    “…In recent years, the incidence of non‑small cell lung cancer (NSCLC) has become the highest lethal rate of cancer worldwide. Molecular assays of EGFR, KRAS,…”
    Get full text
    Journal Article
  20. 20

    CLASRP oncogene as a novel target for colorectal cancer by Gu, Quan, Wu, Jianzhong, Xu, Heng, Cao, Haixia, Zhang, Junying, Jing, Changwen, Wang, Zhuo, Du, Mengjie, Ma, Rong, Feng, Jifeng

    Published in Functional & integrative genomics (01-09-2023)
    “…Clk4-associated serine/arginine-rich protein ( CLASRP ), an alternative splicing regulator, may be involved in the development and progression of cancer by…”
    Get full text
    Journal Article